Dr Mona Mashayekhi MD, PhD
ACTH | Cortisol | Aldosterone | Renin | DHEA | Na | K | ACTH stim | |
---|---|---|---|---|---|---|---|---|
Primary | high | low | low | high | low | low | high | nonreactive |
Central | low | low | wnl | wnl | low-normal* | low** | wnl | reactive $ |
* DHEA has some response to ACTH
** via DDAVP, less extreme hypoNa compared to primary
$ if longstanding central process, ACTH stim will not be normal d/t atrophy
Sheehan - ACTH zero, cortisol zero, ACTH stim will be normal (no time yet for atrophy)
post-op, infx, hemorrhage, mets, autoimmune
More electrolyte abnormalities d/t aldosterone problems (ENAC -> K up, Na down, also some vessel tonicity -> HoTN)
E.g. chronic steroids (causes 1, 2, 3 of AI are iatrogenic d/t steroid use), Sheehans
ACTH cleaved to POMC, melanocortin -> hyperpigmentation (palms more specific)
Prefer hydrocortisone, as has short half-life and allows closer mimicry of physiologic levels. Higher AM dose, lower PM dose.
Relative half-lives and physiologic doses of steroids:
dose | t ½ | |
---|---|---|
dex | 0.25mg | +++ |
pred | 4mg | ++ |
hydro | ? | + |
Common, should suspect if low K and resistant HTN.
Many BP meds modulate HPA axis in some way or another, practically only MRAs are considered sufficiently problematic to interfere with standard testing.
Start with aldo/renin ratio.
Primary therapy is surgical.
MRA therapy can be helpful, but does not prevent other effect of unopposed aldosterone (e.g. cardiac), so preferred when pts are not surgical candidates.
For maximum effectiveness, titrate MRA dose to level of renin.
Adrenal venous sampling (AVS) - done by interventional radiology, highly specialized even within IR.
So some places, if <40yo, will just use CT evidence of nodule to justify removal. (if >40yo, high likelihood of benign adenoma)